Medically important mosquito species belonging to genus Aedes are a major public health concern due to their ability to be efficient vectors of dengue, Chikungunya, Zika, and other arboviruses. Given the limited availability of vaccines and the absence of effective therapeutic treatments for arboviruses, the primary approach to preventing disease transmission is currently focused on controlling populations of Aedes mosquitoes. The incidence of dengue infection has witnessed a substantial surge in recent decades. The observed upward trajectory can be attributed to several factors, namely the rise in long-distance travel, population expansion and urbanization, inadequate sanitation practices, ineffective mosquito control measures, and heightened surveillance and official documentation of dengue occurrences. The conventional management of mosquito vectors through the application of different insecticides has resulted in adverse impacts on the environment and surrounding communities. These include the amplification of toxicity, unintended effects on non-target organisms, and the emergence of resistance in mosquito populations. Hence, it is imperative to develop novel tools and strategies for the management of mosquito vectors associated with these diseases. Recent research has revealed the existence of a wide range of microorganisms, collectively referred to as microbiota, within the midgut and other organs of mosquito vectors. These findings highlight the diverse and ever-changing nature of microbial communities in these organisms. The symbiotic microbiota present in these microbes predominantly contribute to the regulation of mosquito physiology, reproductive capacity, and immune response. The alteration of the midgut microbiota has been proposed to have an impact on the ability of mosquitoes to transmit a range of pathogens, including arboviruses and malaria parasites. Numerous symbiotic bacteria have been investigated for their potential in addressing mosquito-borne diseases, including but not limited to dengue, malaria, Zika, and yellow fever. The potential to cultivate mosquitoes with a predominant bacterial species in their gut microbiota presents an opportunity to explore the use of symbionts for the purpose of inducing antiviral responses or producing antiviral molecules in Aedes mosquitoes.